Gaitanis John N, Drislane Frank W
Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Neurologist. 2003 Mar;9(2):61-76. doi: 10.1097/01.nrl.0000051445.03160.2e.
Status epilepticus (SE) encompasses a wide range of seizure types with different clinical presentations, pathophysiologies, treatment imperatives, and outcomes. The most dramatic and life-threatening form, generalized convulsive status epilepticus, has been reviewed in all of these aspects, but other less common types of SE have been described less extensively.
Definitions of generalized convulsive SE and its pathophysiology are reviewed briefly. Defining SE by a specific duration of seizures is controversial and has implications for studies and for clinical management. Several types of SE are different in their causes, presentations, and outcomes. Many are underdiagnosed. This article focuses on the pharmacology and clinical studies of several anticonvulsant medications used to treat SE. A protocol approach is not detailed. Rather, the clinical evaluation begins with meticulous diagnosis of the type of SE. Establishing the SE syndrome diagnosis and use of anticonvulsants with demonstrated effectiveness facilitate an appropriate treatment plan for individual patients. Recent developments in the basic science of SE raise the possibility of better treatments in the future.
As there are many types of seizures, there are also many types of SE. Each has unique presentations and treatment considerations. Review of actual clinical data from SE treatment studies should be helpful in devising the best treatment for an individual patient.
癫痫持续状态(SE)涵盖多种发作类型,具有不同的临床表现、病理生理学、治疗要点及预后。其中最严重且危及生命的形式——全身惊厥性癫痫持续状态,已在所有这些方面得到综述,但其他较不常见的SE类型描述得较少。
简要回顾了全身惊厥性SE的定义及其病理生理学。通过特定的发作持续时间来定义SE存在争议,且对研究及临床管理有影响。几种类型的SE在病因、表现及预后方面有所不同。许多病例未得到充分诊断。本文重点关注用于治疗SE的几种抗惊厥药物的药理学及临床研究。未详细阐述方案方法。相反,临床评估始于对SE类型的细致诊断。确立SE综合征诊断并使用已证明有效的抗惊厥药物有助于为个体患者制定合适的治疗方案。SE基础科学的最新进展增加了未来更好治疗方法的可能性。
由于发作类型众多,SE的类型也很多。每种都有独特的表现及治疗考量。回顾SE治疗研究的实际临床数据应有助于为个体患者设计最佳治疗方案。